Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Regadenoson

    Client Email Product

    Regadenoson

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    18
    US DMFs Filed

    US DMFs Filed

    12
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    13
    API REF. PRICE (USD / KG)
    4,554,996

    API Market Place

    1
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    12
    Europe

    Europe

    2
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    2

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    18
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Baxter's Generic Regadenoson Monohydrate Receives Receives Approval in the U.S.
    Baxter's Generic Regadenoson Monohydrate Receives Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217455

    FDA
    23 May 2023
    Share Share
    Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal
    Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal

    https://www.astellas.com/en/news/27761

    PRESS RELEASE
    12 May 2023
    Share Share
    Dr Reddy's Laboratories launches Regadenoson injection in US market
    Dr Reddy's Laboratories launches Regadenoson injection in US market

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-laboratories-launches-regadenoson-injection-in-us-market/articleshow/100014221.cms

    ECONOMICTIMES
    05 May 2023
    Share Share
    Mylan's Generic Regadenoson MonohydrateReceives Approval in the U.S.
    Mylan's Generic Regadenoson MonohydrateReceives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213856

    FDA
    04 Apr 2023
    Share Share
    Hikma's Generic Regadenoson Receives Approval in the U.S.
    Hikma's Generic Regadenoson Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215827

    FDA
    02 Feb 2023
    Share Share
    Appeals court sides with Pfizer in patent fight with Astellas
    Appeals court sides with Pfizer in patent fight with Astellas

    https://www.fiercepharma.com/pharma/pfizer-wins-again-patent-fight-its-astellas-over-generic-lexiscan

    Kevin Dunleavy FIERCE PHARMA
    05 Jan 2023
    Share Share
    Eugia's Generic Regadenoson Monohydrate Receives Approval in the U.S.
    Eugia's Generic Regadenoson Monohydrate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216437

    FDA
    26 Oct 2022
    Share Share
    Hospira must wait to launch generic Lexiscan—but only two weeks
    Hospira must wait to launch generic Lexiscan—but only two weeks

    https://www.fiercepharma.com/pharma/patent-fight-against-pfizer-generic-astellas-gets-good-news-and-bad

    Kevin Dunleavy FIERCEPHARMA
    27 Sep 2022
    Share Share
    Hospira's Generic Regadenoson Receives Approval in the U.S.
    Hospira's Generic Regadenoson Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214349

    FDA
    31 Aug 2022
    Share Share
    Delaware court rules against Gilead and Astellas in years-long patent case
    Delaware court rules against Gilead and Astellas in years-long patent case

    https://endpts.com/delaware-court-rules-against-gilead-and-astellas-in-years-long-patent-case/

    Tyler Patchen ENDPTS
    23 May 2022
    Share Share
    Apotex's Generic Regadenoson Receives Approval in the U.S.
    Apotex's Generic Regadenoson Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207604

    FDA
    11 Apr 2022
    Share Share
    Hong Kong's Generic Regadenoson Receives Approval in the U.S.
    Hong Kong's Generic Regadenoson Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212806

    FDA
    11 Apr 2022
    Share Share
    Dr. Reddy's Generic Regadenoson Receives Approval in the U.S.
    Dr. Reddy's Generic Regadenoson Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213210

    FDA
    11 Apr 2022
    Share Share
    Accord Healthcare's Generic Regadenoson Receives Approval in the U.S.
    Accord Healthcare's Generic Regadenoson Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213236

    FDA
    11 Apr 2022
    Share Share
    GE Healthcare’s Stress Agent Rapiscan Approved for use in Imaging Modalities
    GE Healthcare’s Stress Agent Rapiscan Approved for use in Imaging Modalities

    https://www.businesswire.com/news/home/20220211005471/en

    BUSINESSWIRE
    14 Feb 2022
    Share Share
    Dr Reddys Labs Ltd`s Generic Regadenoson Receives Tentative Approval In US
    Dr Reddys Labs Ltd`s Generic Regadenoson Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213210

    FDA
    21 Jan 2021
    Share Share
    Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
    Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma

    https://insight.rpxcorp.com/litigation_documents/13118782

    PATENT LITIGATION
    01 Nov 2018
    Share Share
    ScinoPharm and Nanjing King-friend Biochemical Pharmaceutical Team up to Jointly Enter the Chinese Market for New Drugs
    ScinoPharm and Nanjing King-friend Biochemical Pharmaceutical Team up to Jointly Enter the Chinese Market for New Drugs

    http://www.prnewswire.com/news-releases/scinopharm-and-nanjing-king-friend-biochemical-pharmaceutical-team-up-to-jointly-enter-the-chinese-market-for-new-drugs-282113561.html

    PR NEWS WIRE
    29 Sep 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Farmak Regadenoson

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Biophore Regadenoson Monohydrate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search